KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals

International Immunology

Volumn 20, Issue 4, 2008, Pages 555-563

  Foley, Bree ^a,b   De Santis, Dianne ^a,b   Lathbury, Louise ^a,b   Christiansen, Frank ^a,b   Witt, Campbell ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Activating receptor; Alloreactivity; KIR; NK cell

Indexed keywords

EPITOPE; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR NKG2A;

ALLOIMMUNITY; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL CLONE; CELL CULTURE; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOLYSIS; DONOR; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TARGET CELL;

CELL LINE; CLONING, MOLECULAR; GENOTYPE; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC; RECEPTORS, KIR; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL2;

EID: 41149137750     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn013     Document Type: Article

References (21)

1. Raulet, D. H., Vance, R. E. and McMahon, C. W. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19:291.
2. Kim, S., Poursine-Laurent, J., Truscott, S. M. et al. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 436:709.
3. Biassoni, R., Pessino, A., Malaspina, A. et al. 1997. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur. J. Immunol. 27:3095.
4. Vales-Gomez, M., Reyburn, H. T., Erskine, R. A. and Strominger, J., 1998. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc. Natl Acad. Sci. USA. 95:14326.
5. Colonna, M., Borsellino, G., Falco, M., Ferrara, G. B. and Strominger, J. L. 1993. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl Acad. Sci. USA 90:12000.
6. Moretta, A., Sivori, S., Vitale, M. et al. 1995. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182:875.
7. Stewart, C. A., Laugier-Anfossi, F., Vely, F. et al. 2005. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl Acad. Sci. USA. 102:13224.
8. Chewning, J. H., Gudme, C. N., Hsu, K. C., Selvakumar, A. and Dupont, B. 2007. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J. Immunol. 179:854.
9. Warren, H. S., Kinnear, B. F., Phillips, J. H. and Lanier, L. L. 1995. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J. Immunol. 154:5144.
10. Uhrberg, M., Valiante, N. M., Shum, B. P. et al. 1997. Human diversity in killer cell inhibitory receptor genes. Immunity. 7:753.
11. Sun, J. Y., Gaidulis, L., Miller, M. M. et al. 2004. Development of a multiplex PCR-SSP method for killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens. 64:462.
12. Pende, D. 1996. The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors which is characterised by three lg-like domains and is expressed as a 140 kD disulphide-linked dimer. J. Exp. Med. 184:505.
13. Gavioli, R., Zhang, Q. J. and Masucci, M. G. 1996. HLA-A11-mediated protection from NK cell-mediated lysis: Role of HLA-A11-presented peptides. Hum. Immunol. 49:1.
14. Bauer, S., Groh, V., Wu, J. et al. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:727.
15. Vales-Gomez, M., Reyburn, H. T., Erskine, R. A., Lopez-Botet, M. and Strominger, J. L. 1999. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18:4250.
16. Lopez-Botet, M., Bellon, T., Llano, M., Navarro, F., Garcia, P. and de Miguel, M. 2000. Paired inhibitory and triggering NK cell receptors for HLA class I molecules. Hum. Immunol. 61:7.
17. Robinson, J., Waller, M. J., Parham, P. et al. 2003. IMGT/HLA and IMGT/MHC: Sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res. 31:311.
18. Winter, C. C., Gumperz, J. E., Parham, P., Long, E. O. and Wagtmann, N. 1998. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J. Immunol. 161:571.
19. Saulquin, X., Gastinel, L. N. and Vivier, E. 2003. Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j). J. Exp. Med. 197:933.
20. O'Connor, G. M., Guinan, K. J., Cunningham, R. T., Middleton, D., Parham, P. and Gardiner, C. M. 2007. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J. Immunol. 178:235.
21. McQueen, K. L., Dorighi, K. M., Guethlein, L. A., Wong, R., Sanjanwala, B. and Parham, P. 2007. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation. Hum. Immunol. 68:309.